Dr. Eric Kaplan, MD

NPI: 1770657892
Total Payments
$87,747
2022 Payments
$274.62
Companies
8
Transactions
117

Payment Breakdown by Category

Other$73,590 (83.9%)
Travel$8,092 (9.2%)
Consulting$5,070 (5.8%)
Food & Beverage$995.13 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $73,590 32 83.9%
Travel and Lodging $8,092 50 9.2%
Consulting Fee $5,070 1 5.8%
Food and Beverage $995.13 34 1.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $44,927 49 $0 (2019)
Takeda Pharmaceuticals America, Inc. $35,675 55 $0 (2017)
Janssen Pharmaceuticals, Inc $6,832 8 $0 (2022)
Supernus Pharmaceuticals, Inc. $124.67 1 $0 (2021)
Jazz Pharmaceuticals Inc. $124.59 1 $0 (2020)
Indivior Inc. $34.64 1 $0 (2018)
Alkermes, Inc. $16.82 1 $0 (2021)
Allergan Inc. $13.50 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $274.62 1 Janssen Pharmaceuticals, Inc ($274.62)
2021 $5,698 8 Janssen Pharmaceuticals, Inc ($5,557)
2020 $124.59 1 Jazz Pharmaceuticals Inc. ($124.59)
2019 $11,445 8 Takeda Pharmaceuticals U.S.A., Inc. ($10,445)
2018 $32,080 37 Takeda Pharmaceuticals U.S.A., Inc. ($32,045)
2017 $38,125 62 Takeda Pharmaceuticals America, Inc. ($35,675)

All Payment Transactions

117 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
01/06/2022 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging Cash or cash equivalent $274.62 General
Category: Neuroscience
10/27/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Consulting Fee Cash or cash equivalent $5,070.00 General
Category: Neuroscience
10/23/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Travel and Lodging In-kind items and services $366.37 General
Category: Neuroscience
10/23/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $44.65 General
Category: Neuroscience
10/23/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $31.25 General
Category: Neuroscience
10/23/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $22.31 General
Category: Neuroscience
10/23/2021 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $22.31 General
Category: Neuroscience
08/04/2021 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage In-kind items and services $124.67 General
Category: PSYCHOLOGY
06/03/2021 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $16.82 General
Category: CNS
01/24/2020 Jazz Pharmaceuticals Inc. SUNOSI (Drug) Food and Beverage In-kind items and services $124.59 General
Category: NEUROLOGY
04/24/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: Neuroscience
02/08/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,480.00 General
Category: Central Nervous System (CNS)
02/08/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $371.20 General
Category: Central Nervous System (CNS)
01/29/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage Cash or cash equivalent $32.00 General
Category: Central Nervous System (CNS)
01/03/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: Central Nervous System (CNS)
01/03/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $283.40 General
Category: Central Nervous System (CNS)
01/02/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: Central Nervous System (CNS)
01/02/2019 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $277.95 General
Category: Central Nervous System (CNS)
12/12/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: Central Nervous System (CNS)
12/12/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $321.55 General
Category: Central Nervous System (CNS)
12/12/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $190.97 General
Category: Central Nervous System (CNS)
12/12/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $8.00 General
Category: Central Nervous System (CNS)
12/06/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Central Nervous System (CNS)
12/04/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,520.00 General
Category: Central Nervous System (CNS)
12/04/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Travel and Lodging Cash or cash equivalent $196.20 General
Category: Central Nervous System (CNS)

About Dr. Eric Kaplan, MD

Dr. Eric Kaplan, MD is a Psychiatry healthcare provider based in Lutz, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770657892.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Kaplan, MD has received a total of $87,747 in payments from pharmaceutical and medical device companies, with $274.62 received in 2022. These payments were reported across 117 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($73,590).

Practice Information

  • Specialty Psychiatry
  • Location Lutz, FL
  • Active Since 11/20/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1770657892

Products in Payments

  • Trintellix (Drug) $80,405
  • SPRAVATO (Drug) $6,832
  • Entyvio (Biological) $196.20
  • QELBREE (Drug) $124.67
  • SUNOSI (Drug) $124.59
  • SUBLOCADE (Drug) $34.64
  • VIVITROL (Drug) $16.82
  • VRAYLAR (Drug) $13.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Lutz